These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 9652368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635.
    Critchley DJ, Childs KJ, Middlefell VC, Dourish CT.
    Eur J Pharmacol; 1994 Oct 13; 264(1):95-7. PubMed ID: 7828650
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.
    Meller E, Bohmaker K.
    J Pharmacol Exp Ther; 1994 Dec 13; 271(3):1246-52. PubMed ID: 7996433
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 9. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
    Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD.
    Brain Res; 1993 Dec 10; 630(1-2):148-56. PubMed ID: 8118681
    [Abstract] [Full Text] [Related]

  • 10. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome.
    Osei-Owusu P, James A, Crane J, Scrogin KE.
    J Pharmacol Exp Ther; 2005 Jun 10; 313(3):1324-30. PubMed ID: 15743927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1990 Apr 10; 126(4):1888-94. PubMed ID: 2156670
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
    Zuideveld KP, Treijtel N, Maas HJ, Gubbens-Stibbe JM, Peletier LA, van Der Graaf PH, Danhof M.
    J Pharmacol Exp Ther; 2002 Jan 10; 300(1):330-8. PubMed ID: 11752133
    [Abstract] [Full Text] [Related]

  • 18. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 19. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
    Bardin L, Tarayre JP, Koek W, Colpaert FC.
    Eur J Pharmacol; 2001 Jun 08; 421(2):109-14. PubMed ID: 11399266
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ, Moerschbaecher JM.
    Behav Pharmacol; 2000 Nov 08; 11(7-8):535-53. PubMed ID: 11198126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.